Apicola de Allende, S.A. de C.V. · 99-39 · MEXICO
For Apicola de Allende, S.A. de C.V., import alert is 99-39; country is MEXICO; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; product is Royal Jelly | Royal Jelly Capsules | Propolis Liquid Extract Drops | Propolis Capsules | Bee Pollen | EspectiBron; product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human); date published is 04/24/2017; address is Lerdo De Tejada No. 202 Ote. , Col. Centro Seccion , Allende, Nuevo Leon MEXICO, verified against its source on 2026-09-30.
- Firm
- Apicola de Allende, S.A. de C.V. verified
- Import alert
- 99-39
- Import alert name
- Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- Country
- MEXICO verified
- Address
- Lerdo De Tejada No. 202 Ote. , Col. Centro Seccion , Allende, Nuevo Leon MEXICO verified
- Date published
- 04/24/2017 verified
- Product code
- 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) each item verified
- Product
- Royal Jelly | Royal Jelly Capsules | Propolis Liquid Extract Drops | Propolis Capsules | Bee Pollen | EspectiBron each item verified
- FDA notes
- The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. The product appears to be misbranded within the meaning of section 403(q)(1)(B) because the label fails to declare the servings per container in accordance with 21CFR 101.36(b)(1)(ii). | The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. | The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. | The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. | The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of 403(r)(2)(A) of the Act [21U.S.C. § 343 (r)(2)(A)] because the label makes a claim stating the absence of a nutrient which is not in accordance with 21CFR 101.13(e)(2). | The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. The product appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act [21U.S.C. § 343(q)(5)(F)] in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36. each item verified
What the source says
Apicola de Allende, S.A. de C.V. Date Published : 04/24/2017 Lerdo De Tejada No. 202 Ote. , Col. Centro Seccion , Allende, Nuevo Leon MEXICO
— accessdata.fda.gov, retrieved 2026-09-22
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: Royal Jelly Notes: The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. The product appears to be misbranded within the meaning of section 403(q)(1)(B) because the label fails to declare the servings per container in accordance with 21CFR 101.36(b)(1)(ii). 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: Royal Jelly Capsules Notes: The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: Propolis Liquid Extract Drops Notes: The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: Propolis Capsules Notes: The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: Bee Pollen Notes: The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of 403(r)(2)(A) of the Act [21U.S.C. § 343 (r)(2)(A)] because the label makes a claim stating the absence of a nutrient which is not in accordance with 21CFR 101.13(e)(2). 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 04/24/2017 Desc: EspectiBron Notes: The product appears to be misbranded within the meaning of: section 403(f) of the Act [21 U.S.C. §343(f)] because the product labels contain information in multiple languages, but do not repeat all the required information in all languages. The product appears to be misbranded within the meaning of: Section 403(y) of the Act in that the product labels fail to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The product appears to be misbranded within the meaning of section 403(q)(1)(A) of the Act [21U.S.C. § 343(q)(1)(A)] because the serving size declared on the labels are incorrect. The product appears to be misbranded within the meaning of section 403(q)(5)(F) of the Act [21U.S.C. § 343(q)(5)(F)] in that the presentation of the nutrition information on the labeling does not comply with 21CFR 101.36.
— all from accessdata.fda.gov, retrieved 2026-09-22
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_1144.html